September 13, 2026, Peptides Now! - Khavinson's Blend - Deep Dive with Alex and Jessica
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
-
Letto da:
-
Di:
Title: September 13, 2026, Peptides Now! - Khavinson's Blend - Deep Dive with Alex and Jessica
Keep the momentum at: https://www.v2u.us/subscribe
If you’ve found this episode informative, insightful or beneficial, don’t forget to like and share with someone who may also benefit.
Primary Keyword Cluster: Khavinson peptides, Epitalon longevity, FDA peptide regulations 2026, anti aging peptide therapy, cellular signaling
Description: Join hosts Alex and Jessica for an in-depth deep dive into Khavinson peptide bioregulators and the evolving regulatory landscape of cellular therapeutics in 2026. This episode explores the 12 hallmarks of aging, direct versus indirect energy peptides, and the controversial July 2026 FDA advisory committee review of Epitalon. Discover the rigorous science, safety concerns, and clinical realities driving modern longevity medicine.
• Decoding Cellular Text Messages: Explore how short-chain peptides act as targeted chemical commands addressing specific root mechanisms within the expanded 12 hallmarks of aging framework.
• Direct vs Indirect Energy Peptides: Examine the critical distinction between direct mitochondrial ATP enhancers like SS-31 Elamipretide and indirect metabolic secretagogues like Sermorelin and BPC-157.
• Khavinson Epitalon and FDA Regulations: Unpack the mechanics of Epitalon AEDG tetrapeptide, the 7-5 FDA advisory committee recommendation for compounding, and vital safety considerations between free base and acetate salt forms.
Timestamps:
• 0:00 – Introduction to Peptide Cellular Commands
• 2:45 – The 12 Hallmarks of Aging Framework
• 5:30 – Direct vs Indirect Energy Peptides
• 9:15 – SS-31 Elamipretide and Mitochondrial Approval
• 12:40 – Khavinson Peptides and Epitalon AEDG Mechanics
• 16:10 – The July 2026 FDA PCAC Advisory Committee Vote
• 19:25 – Free Base vs Acetate Salt Formulations
• 21:50 – Stacking Protocols, COAs, and Final Takeaways
Don't miss our next episode, where we'll continue to unravel the latest in AI innovation and market trends.
Tags and Keywords: #peptides, #khavinson, #epitalon, #longevity, #antiaging, #fdaregulations, #bioregulators